Table 3.
Pooled outcome measures of the studies with both intervention and control arms
| SBP baseline (mmHg) | SBP end (mmHg) | DBP baseline (mmHg) | DBP end (mmHg) | ||
|---|---|---|---|---|---|
| Intervention | Bekiroglu [18] | 128.2 (6.7) | 115.2 (5.3) | 77.5a(−) | 70.0a(−) |
| Zanini [19] | 149.7 (6.4) | 133.8 (13.4) | 89.1 (9.1) | 80.1 (10.6) | |
| Chan [20] | 143.8 (23.8) | 130.1 (28.1) | 73.1 (11.5) | 67.7 (14.0) | |
| Heterogeneity | X 2 P < 0.001 | X 2 P < 0.001 | X 2 P < 0.001 | X 2 P < 0.001 | |
| I2 = 99 % | I2 = 96 % | I2 = 96 % | I2 = 91 % | ||
| R-E model | 140.4 | 126.0 | 81.2 | 74.1 | |
| (95 % CI) | (123.7–157.2) | (111.5–140.5) | (65.5–96.9) | (61.9–86.2) | |
| F-E model | 138.2 | 117.5 | 82.9 | 75.6 | |
| (95 % CI) | (136.5–140.0) | (115.7–119.2) | (80.0–85.9) | (72.1–79.0) | |
| Control | Bekiroglu [18] | 121.2 (5.9) | 114.7 (6.0) | 80.0a(−) | 70.0a(−) |
| Zanini [19] | 145.4 (5.6) | 141.0 (19.8) | 86.9 (11.3) | 83.9 (12.4) | |
| Chan [20] | 143.7 (22.1) | 140.9 (26.4) | 72.7 (12.8) | 71.4 (13.6) | |
| Heterogeneity | X 2 P < 0.001 | X 2 P < 0.001 | X 2 P < 0.001 | X 2 P = 0.001 | |
| I2 = 99 % | I2 = 96 % | I2 = 94 % | I2 = 91 % | ||
| R-E model | 136.6 | 131.8 | 79.8 | 77.7 | |
| (95 % CI) | (117.6–155.6) | (110.9–152.7) | (65.9–93.8) | (65.4–89.9) | |
| F-E model | 132.5 | 117.3 | 80.4 | 78.0 | |
| (95 % CI) | (130.9–134.0) | (115.2–119.3) | (76.9–83.9) | (74.2–81.7) |
Data expressed as “mean (SD)”, “mean (95 % CI)” or proportions
R-E model random-effects model, F-E model fixed-effect model, SBP systolic blood pressure, DBP diastolic blood pressure
aExcluded from analysis due to unavailable measures of dispersion